Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Posluma PET Scan for Early Prostate Cancer Recurrence
NCT06617481Phase 2Recruiting
- Sponsor
- AdventHealth
- Start
- Sep 2024
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fludeoxyglucose f 18 in prostate cancer (PCa), sponsored by AdventHealth. Started Sep 2024; status: recruiting.
02
Drugs
fludeoxyglucose f 18
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT06617481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06617481.